发明名称 |
Process for the preparation of a pharmaceutical composition comprising ezetimibe |
摘要 |
The present invention belongs to the field of pharmaceutical industry and relates to a process for preparing dosage forms containing ezetimibe, comprising the steps of:
a) providing a composition comprising ezetimibe,b) sieving a composition comprising a composition of step (a),c) shear mixing of the composition after step (b), preferably the mixing of the composition is carried out by high shear mixing,d) formulation into a dosage form.;The present invention also relates to dosage forms containing ezetimibe and ezetimibe and simvastatin, which have been prepared according to the process according to the invention. |
申请公布号 |
US9089486(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US201013147956 |
申请日期 |
2010.02.05 |
申请人 |
LEK PHARMACEUTICALS D.D. |
发明人 |
Kerc Janez;Homar Miha;Jurkovic Polona |
分类号 |
A61K9/14;A61K9/20;A61K31/366;A61K31/397;A61P3/06 |
主分类号 |
A61K9/14 |
代理机构 |
Arent Fox LLP |
代理人 |
Arent Fox LLP |
主权项 |
1. A process for preparing a dosage form, the process consisting essentially of the steps:
(a) providing a starting composition of particulates of ezetimibe and a hydrophilic excipient, (b) sieving a composition provided by step (a), (c) high shear mixing of the composition after step (b), and (d) formulation into a dosage form by direct compression, wherein said high shear mixing is carried out at a paddle speed of at least 100 RPM; wherein step (b) occurs before step (c); wherein the size of the particles d (0.9) of ezetimibe in the starting composition is between 8 and 25 μm and is essentially unchanged during the process; wherein the process is conducted under dry conditions without a solvent; wherein after (c) no further ingredients are added and no further mixing or sieving is performed; and wherein, when the produced dosage form is analyzed in a USP Apparatus 2 (paddles) in 0.01 M HCl and 0.25% sodium lauryl sulfate, more than 50% dissolves within 15 minutes. |
地址 |
Ljubljana SI |